Extracellular matrix components and hemidesmosomal adhesion complexes (ECM-HAC)

Extracellular matrix (ECM) components and hemidesmosomal adhesion complexes represent a specialized structural framework essential for the mechanical attachment of epithelial cells to the underlying connective tissue. Hemidesmosomes are multiprotein units that link the intracellular keratin cytoskeleton to the basement membrane through key transmembrane proteins, including Integrin alpha-6 beta-4 and Type XVII collagen (BP180) (Walko et al., 2015, J Cell Sci). The associated ECM environment consists of laminins (specifically Laminin-332), type IV collagen, and anchoring fibrils composed of type VII collagen, which together ensure tissue stability and resistance to shear forces (Borradori & Sonnenberg, 1999, J Invest Dermatol). These complexes are of significant clinical importance as they are the primary targets in various severe pathologies. Genetic mutations in components like LAMA3 or COL17A1 result in junctional epidermolysis bullosa, a condition characterized by extreme skin fragility and blistering (UniProt P08581, Q9UMD9). Furthermore, these proteins are the targets of autoantibodies in subepidermal blistering diseases such as bullous pemphigoid, where the immune system attacks BP180 or BP230 (StatPearls, 2023). In oncology, the remodeling of these adhesion complexes and their signaling through integrins are frequently exploited by carcinoma cells to promote migration, invasion, and survival, making them relevant targets for both dermatological and anti-cancer therapeutic interventions.

Other names

Dermal-epidermal junction componentsHemidesmosome-anchoring filament complexBasement membrane zone proteinsCell-matrix adhesion complex

Therapeutic strategies typically involve the depletion of B-cells to reduce autoantibody production against complex components, systemic immunosuppression to prevent inflammatory destruction of the adhesion complex, or the use of monoclonal antibodies to inhibit specific inflammatory interleukins (e.g., IL-4/IL-13) that exacerbate tissue damage at the basement membrane zone.